Page last updated: 2024-11-05

tetraethylammonium and Cardiac Hypertrophy

tetraethylammonium has been researched along with Cardiac Hypertrophy in 2 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walsh, KB1
Sweet, JK1
Parks, GE1
Long, KJ1
Cameron, JS1
Kimura, S1
Jackson-Burns, DA1
Smith, DB1
Bassett, AL1

Other Studies

2 other studies available for tetraethylammonium and Cardiac Hypertrophy

ArticleYear
Modulation of outward potassium currents in aligned cultures of neonatal rat ventricular myocytes during phorbol ester-induced hypertrophy.
    Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:6

    Topics: Animals; Cardiomegaly; Cells, Cultured; Delayed Rectifier Potassium Channels; Electric Conductivity;

2001
ATP-sensitive K+ channels are altered in hypertrophied ventricular myocytes.
    The American journal of physiology, 1988, Volume: 255, Issue:5 Pt 2

    Topics: 4-Aminopyridine; Adenosine Triphosphate; Aminopyridines; Animals; Calcium; Cardiomegaly; Cats; Dose-

1988